Pellegrini Niamh Louise
Insider CIK 1620611 · NVRO Chief Commercial Officer · AFIB Director · THOR President, North America
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AFIB Acutus Medical, Inc. | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 20,972 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2023-05-28 | 2023-05-31 | 1,143 | $26.45 | $30.2K | 85,967 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2023-03-07 | 2023-03-09 | 39,282 | — | $0 | 87,110 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2023-03-02 | 2023-03-06 | 1,979 | $33.99 | $67.3K | 47,828 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2023-02-28 | 2023-03-02 | 4,718 | $31.44 | $148.3K | 49,807 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2022-08-06 | 2022-08-08 | 4,365 | $47.11 | $205.6K | 54,525 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 12,572 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2022-03-02 | 2022-03-04 | 2,031 | $71.27 | $144.7K | 58,890 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2022-02-28 | 2022-03-02 | 26,069 | — | $0 | 60,921 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2021-08-10 | 2021-08-12 | 15,191 | — | $0 | 15,191 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2021-08-10 | 2021-08-12 | 4,172 | — | $0 | 4,172 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2021-08-06 | 2021-08-10 | 4,366 | $119.73 | $522.7K | 34,852 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2021-03-10 | 2021-03-12 | 750 | — | $0 | 65,575 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2021-03-10 | 2021-03-12 | 750 | $64.95 | $48.7K | 39,968 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2021-03-10 | 2021-03-12 | 750 | $148.08 | $111.1K | 39,218 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2021-03-02 | 2021-03-04 | 706 | $168.11 | $118.7K | 39,218 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2021-03-02 | 2021-03-04 | 9,596 | — | $0 | 39,924 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2021-02-10 | 2021-02-12 | 750 | — | $0 | 66,325 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2021-02-10 | 2021-02-12 | 750 | $182.55 | $136.9K | 30,328 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2021-02-10 | 2021-02-12 | 750 | $64.95 | $48.7K | 31,078 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2021-01-11 | 2021-01-13 | 750 | — | $0 | 67,075 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2021-01-11 | 2021-01-13 | 750 | $169.80 | $127.4K | 30,328 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2021-01-11 | 2021-01-13 | 750 | $64.95 | $48.7K | 31,078 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-12-10 | 2020-12-14 | 750 | — | $0 | 67,825 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-12-10 | 2020-12-14 | 450 | $160.72 | $72.3K | 30,328 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-12-10 | 2020-12-14 | 750 | $64.95 | $48.7K | 31,078 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-12-10 | 2020-12-14 | 300 | $161.96 | $48.6K | 30,778 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-11-10 | 2020-11-12 | 750 | — | $0 | 68,575 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-11-10 | 2020-11-12 | 750 | $64.95 | $48.7K | 31,078 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-11-10 | 2020-11-12 | 750 | $170.75 | $128.1K | 30,328 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-10-22 | 2020-10-26 | 1,817 | $165.00 | $299.8K | 30,328 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-10-19 | 2020-10-21 | 1,000 | $155.00 | $155.0K | 32,145 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-10-13 | 2020-10-13 | 750 | — | $0 | 69,325 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-10-13 | 2020-10-13 | 750 | $151.47 | $113.6K | 33,145 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-10-13 | 2020-10-13 | 750 | $64.95 | $48.7K | 33,895 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-10-09 | 2020-10-13 | 1,000 | $150.00 | $150.0K | 33,145 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-09-10 | 2020-09-14 | 750 | — | $0 | 70,075 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-09-10 | 2020-09-14 | 750 | $139.14 | $104.4K | 34,145 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-09-10 | 2020-09-14 | 750 | $64.95 | $48.7K | 34,895 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-08-10 | 2020-08-10 | 750 | — | $0 | 70,825 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-08-10 | 2020-08-10 | 750 | $64.95 | $48.7K | 34,895 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-08-10 | 2020-08-10 | 750 | $140.11 | $105.1K | 34,145 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2020-08-06 | 2020-08-10 | 4,476 | $141.77 | $634.6K | 34,145 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2020-03-02 | 2020-03-04 | 5,446 | — | $0 | 38,621 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2019-07-15 | 2019-07-17 | 71,575 | — | $0 | 71,575 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2019-07-15 | 2019-07-17 | 33,175 | — | $0 | 33,175 | SEC↗ |
| THOR THORATEC CORP | D To issuer deriv | 2015-10-08 | 2015-10-08 | 74,627 | $37.73 | $2.82M | 0 | SEC↗ |
| THOR THORATEC CORP | D To issuer | 2015-10-08 | 2015-10-08 | 51,928 | $63.50 | $3.30M | 0 | SEC↗ |
| THOR THORATEC CORP | A Award | 2015-10-08 | 2015-10-08 | 11,228 | — | $0 | 51,928 | SEC↗ |
| THOR THORATEC CORP | A Award | 2015-03-16 | 2015-03-16 | 13,099 | — | $0 | 40,700 | SEC↗ |
| THOR THORATEC CORP | A Award deriv | 2014-10-15 | 2014-10-15 | 74,627 | — | $0 | 74,627 | SEC↗ |
| THOR THORATEC CORP | A Award | 2014-10-13 | 2014-10-15 | 27,601 | — | $0 | 27,601 | SEC↗ |